︎
 ︎︎︎ become a partner of CRSy26 ︎︎︎ looking for a place to stay during CRSy26? take a look at our partner hotels! ︎︎︎ didn’t register? get your live streaming ticket ︎︎︎ join >250 participants from 13 countries and 28 institutions worldwide ︎︎︎ 4 keynote talks, 13 invited speakers, 7 selected talks, 2 poster sessions ︎︎︎ tours, meet the speaker, a boat trip, and a dinner party await. check the full social programme here 


︎    ︎    ︎    

Ana Luísa Correia, PhD


Champalimaud Foundation

Lisbon, Portugal

Ana Luísa Correia received her B.Sc. in Applied Biology from the University of Minho, Portugal. As a student of the GABBA program, she pursued her PhD studies on the role of the microenvironment in breast cell invasion at the Lawrence Berkeley Lab, USA, and then a postdoc at the FMI and the University of Basel, Switzerland, investigating how tissue-specific microenvironments shape metastasis formation. She is internationally recognized for discovering an immune-stroma axis controlling cancer progression from dormancy to metastasis in the liver. Ana is currently a Principal Investigator at the Champalimaud Foundation, where she leads the Cancer Dormancy & Immunity Lab. The goal of her research is to determine the principles guiding antimetastatic tissue responses, and leverage this knowledge into therapeutic strategies that reliably prevent metastases. Ana has received a few international awards (2021 Metastasis Research Prize, 2022 Pfizer Oncology, AACR 2022 NextGen Stars), is an EMBO Young Investigator, and serves as an active member at the EACR, AACR and MRS societies.

︎ Visit the speaker’s lab here